Alessandro Armuzzi to Italy
This is a "connection" page, showing publications Alessandro Armuzzi has written about Italy.
Connection Strength
0.171
-
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020 08; 8(7):775-781.
Score: 0.037
-
Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. Dig Liver Dis. 2017 Dec; 49(12):1298-1305.
Score: 0.030
-
Psychological reaction to Covid-19 of Italian patients with IBD. BMC Psychol. 2021 Aug 06; 9(1):115.
Score: 0.010
-
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey. Inflamm Bowel Dis. 2020 10 23; 26(11):e134-e136.
Score: 0.009
-
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care. United European Gastroenterol J. 2020 12; 8(10):1228-1235.
Score: 0.009
-
Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care. Inflamm Bowel Dis. 2020 09 18; 26(10):e130-e131.
Score: 0.009
-
Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020 07; 69(7):1213-1217.
Score: 0.009
-
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1361-1369.
Score: 0.009
-
Physicians' Knowledge and Application of Immunization Strategies in Patients with Inflammatory Bowel Disease: A Survey of the Italian Group for the Study of Inflammatory Bowel Disease. Digestion. 2020; 101(4):433-440.
Score: 0.009
-
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study. Dig Liver Dis. 2019 04; 51(4):510-515.
Score: 0.008
-
Unmet needs of Italian physicians managing patients with inflammatory bowel disease. Dig Liver Dis. 2019 02; 51(2):212-217.
Score: 0.008
-
How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey. Dig Liver Dis. 2018 07; 50(7):734-736.
Score: 0.008
-
Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. Dig Liver Dis. 2017 Jun; 49(6):604-617.
Score: 0.007
-
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD). Dig Liver Dis. 2017 04; 49(4):338-358.
Score: 0.007